Clinical Practice, Provider and Vaccination

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Practice

Provider

Vaccination

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Medical Xpress

JULY 1, 2025

Im hopeful that the genomic information from this and future studies will guide choices of chemotherapies, and their adoption in clinical practice." The content is provided for information purposes only. More information: The long-term effects of chemotherapy on normal blood cells, Nature Genetics (2025).

Patients

Patients Individual Medical Diabetes

FDA’s New RWE Guidance Provides Recommendations for Sponsors Conducting Non-Interventional Real-World Studies and Describes the Potential to Use RWE for Initial Approvals in One Limited Circumstance

FDA Law

SEPTEMBER 10, 2023

Even though an IND is not required, this guidance is intended to provide recommendations for sponsors to follow for using RWE from such studies for regulatory decision-making. The COVID-19 vaccines were initially authorized under EUAs, but their approvals do not appear to have been based on RWE.

Provider

Provider Patient-Centered Clinic Clinical Practice

Webinars

How to Start Virtual Care the Right Way: A Proven Roadmap for 2025 and Beyond

MORE WEBINARS

Primary Care Digest

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

FDA’s New RWE Guidance Provides Recommendations for Sponsors Conducting Non-Interventional Real-World Studies and Describes the Potential to Use RWE for Initial Approvals in One Limited Circumstance

Webinars

Stay Connected